tirzepatide 0.5 ml Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Dosing - A Patient

Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound

Histamine and the striatum

Lawsuit Against Ozempic for Stomach Paralysis [2025 Update]

Mounjaro and Zepbound contain tirzepatide, a dual GLP-1/GIP agonist

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks Semaglutide, a GLP-1 receptor agonist from Novo Nordisk, originally developed to treat diabetes, has been approved by the U.S

At the start of this year, and definitely in the last two quarters of last year, we were running into a lot of shortages of Ozempic for our patients with type 2 diabetes, said Dr